A recent Radiology digest,
as sent to subscribers

Study Type: Cannot be determined. The abstract field is empty. The title suggests a statistical methods paper or commentary on variance decomposition, but this is inference only.

Key Question: Not stated. The title implies the paper addresses which factors drive variability between US states, possibly in imaging utilisation or outcomes, but this cannot be confirmed.

Key Findings:

• No abstract text was provided, so no findings, effect sizes, or confidence intervals can be reported.
• Please supply the abstract or full text for a proper summary.

Clinical Relevance: Cannot be assessed without content. If the paper concerns methodology for analysing geographic variation, it may have indirect relevance to unwarranted variation work in the NHS (e.g., GIRFT, regional imaging utilisation), but this is speculative.

Limitations: Summary is not possible due to the absent abstract; any interpretation would risk fabrication.

Study Type: Cannot be determined from the title alone. The wording suggests a commentary or review of litigation cases, but this is unconfirmed.

Key Question: Presumably, what do malpractice claims involving obstetric ultrasound reporting reveal about reporting practice and risk? This is inferred from the title only.

Key Findings:

• No abstract was provided, so no data, case numbers, themes, or conclusions can be reported.
• The full text would be needed to identify the litigation sources, jurisdiction, and recommendations.

Clinical Relevance: If the article analyses litigation themes in obstetric ultrasound reporting, it may inform reporting standards and medicolegal risk awareness, though the source appears to be US-based and may not map directly onto NHS practice and NHS Resolution processes.

Limitations: No abstract available, so the study design, methods, and findings cannot be assessed; please supply the abstract or full text for a proper summary.

Study Type: Cannot be determined from the information provided. The title suggests a narrative review or educational/instructional article (possibly part of a "how to" series) rather than original research, but this is inference only.

Key Question: Presumably how radiology clinicians and researchers should approach ethical issues in data use and research, but this cannot be confirmed without the abstract.

Key Findings: None available. No abstract content was supplied.

Clinical Relevance: Data governance and research ethics (e.g., consent, data sharing, AI training datasets) are relevant to UK radiology practice, but the specific content of this article cannot be assessed.

Limitations: Not assessable without the abstract. Please paste the full abstract and I will produce the structured summary.

What the title suggests (inference only, not a finding): This appears to be an opinion or commentary piece in AJR on how AI use by hospital administrators and insurers may escalate administrative costs and patient expenditure. It is unlikely to be original empirical research, though this can't be confirmed without the abstract.

To proceed: Please paste the full abstract text, and I will complete the summary in the standard format. If it is confirmed as a commentary or editorial, I will adapt the structure accordingly and omit the Limitations section.

Note on UK relevance: The article is likely US-centred (insurer and prior-authorisation context). Its direct applicability to NHS commissioning and reporting pathways may be limited, which I would address under Clinical Relevance once the content is available.

Study Type: Retrospective single-centre pilot study (78 lesions, 27 patients).

Key Question: Does combining ADC-based DWI response criteria with RECIST 1.1 improve early assessment of systemic therapy response in lung cancer pelvic bone metastases?

Key Findings:

• ADC thresholds (>1300 µm²/s or ΔADC >0.14) were derived from ROC analysis against later lesion size change, then combined with RECIST as "DWI-RECIST".
• DWI-RECIST gave modest net reclassification gains (7.4% and 11.1% for the two readers) against RECIST at TP2 as reference. AUC improvements were not significant (0.696 vs 0.618, p=0.472; 0.642 vs 0.618, p=0.781).
• Interobserver agreement for ADC was good (ICC 0.83–0.86).

Clinical Relevance: Bone metastases are non-measurable under RECIST 1.1 in most NHS practice, so functional DWI markers could aid early response assessment, particularly in lesions classed as stable disease, but this remains hypothesis-generating.

Limitations: Thresholds were derived and tested in the same small cohort without external validation, and RECIST at TP2 is an imperfect reference standard for bone disease.

Study Type: Retrospective, single-centre, multi-reader study with sequential unaided/AI-assisted reads (5 radiologists, 150 CEM examinations, ≥4-week washout)

Key Question: Does a deep-learning CAD tool improve radiologists' diagnostic accuracy and reading efficiency in contrast-enhanced mammography (CEM)?

Key Findings:

• Lesion-level performance improved for most readers: mean AFROC AUC increase of 0.030 ± 0.018.
• At 89% sensitivity, false positives fell by a mean of 11.4% ± 24%, with wide inter-reader variability.
• No improvement at breast level; reading time fell 31% in one radiologist (exploratory, single reader).

Clinical Relevance: CEM is increasingly used in UK practice as an alternative to MRI, and AI support that lowers false positives and reading time could aid workload, though evidence is still early.

Limitations: Small, single-centre retrospective dataset with a single-view tool, an enriched case mix and an efficiency finding from one reader limit generalisability to real-world prospective workflows.

Study Type: Cross-sectional online questionnaire survey of authors (small sample, n = 34).

Key Question: Why do radiology authors develop and publish multivariable regression models, and are these models evaluated externally or used clinically?

Key Findings:

• 49% (17/35) had no intention of external evaluation; main barriers were lack of time (27%), funding (22%) and interest in development alone (19%).
• 67% (23/34) reported no or little statistical support; 29% (10/34) cited career progression as a motivation for publication.
• 82% (28/34) did not use their own model clinically, 56% (19/34) believed others would not, and 79% (27/34) did not use models in general.

Clinical Relevance: For UK radiologists appraising or considering adopting published prediction models (including AI-adjacent tools), this suggests many lack external validation or real-world uptake, so critical appraisal of validation status is warranted before clinical use.

Limitations: Very small sample with an unreported response rate, so non-response bias is likely and findings may not generalise to all authors; the authors' conclusion on clinical utility is inferred from self-report rather than directly measured.

Study Type: Proof-of-concept experimental study (in vitro phantom calibration with small prospective patient evaluation, n=12).

Key Question: Can a cytogenetic dose-response curve built in an anthropomorphic phantom predict chromosomal aberration yields in radiotherapy patients after a single fraction?

Key Findings:

• Phantom-irradiated blood (6 MV photons, single-fraction glioblastoma and breast plans, 2.0 and 2.67 Gy PTV doses) gave a Dic+CR dose-response curve that fitted the linear-quadratic model well.
• In 12 patients (5 glioblastoma, 7 breast), predicted yields from individual dose-volume data were the same order of magnitude as observed yields, but underestimated them in 10 of 12.
• Correlation between expected and observed yields was positive but non-significant (r = 0.39, p = 0.21).

Clinical Relevance: Early-stage work toward biological verification of delivered dose in radiotherapy; not applicable to routine NHS practice, but of potential interest for future dose-verification and radiobiological monitoring research.

Limitations: Calibration used blood from a single healthy donor and the patient sample was very small, so in vivo biological variability could not be assessed and the study was underpowered to show correlation.